Jamie M Stagl1, Laura C Bouchard2, Suzanne C Lechner3,4, Bonnie B Blomberg4,5, Lisa M Gudenkauf2, Devika R Jutagir2, Stefan Glück4, Robert P Derhagopian6, Charles S Carver2,4, Michael H Antoni2,3,4. 1. Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts. 2. Department of Psychology, University of Miami, Coral Gables, Florida. 3. Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, Florida. 4. Sylvester Cancer Center, University of Miami Miller School of Medicine, Miami, Florida. 5. Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida. 6. Baptist Health Breast Center, Miami, Florida.
Abstract
BACKGROUND:Breast cancer survivors experience long-term physical and psychological sequelae after their primary treatment that negatively influence their quality of life (QOL) and increase depressive symptoms. Group-based cognitive-behavioral stress management (CBSM) delivered after surgery for early-stage breast cancer was previously associated with better QOL over a 12-month follow-up and with fewer depressive symptoms up to 5 years after study enrollment. This 8- to 15-year follow-up (median, 11 years) of a previously conducted trial (NCT01422551) evaluated whether women in this cohort receiving CBSM had fewer depressive symptoms and better QOL than controls at an 8- to 15-year follow-up. METHODS:Women with stage 0 to IIIb breast cancer were initially recruited 2 to 10 weeks after surgery and randomized to a 10-week CBSM intervention or a 1-day psychoeducational control group. One hundred women (51 CBSM patients and 49 controls) were recontacted 8 to 15 years after study enrollment to participate in a follow-up assessment. The Center for Epidemiologic Studies-Depression (CES-D) scale and the Functional Assessment of Cancer Therapy-Breast (FACT-B) were self-administered. Multiple regression was employed to evaluate group differences on the CES-D scale and FACT-B over and above effects of confounding variables. RESULTS: Participants assigned to CBSM reported significantly lower depressive symptoms (d, 0.63; 95% confidence interval [CI], 0.56-0.70) and better QOL (d, 0.58; 95% CI, 0.52-0.65) above the effects of the covariates. CONCLUSIONS: Women who received CBSM after surgery for early-stage breast cancer reported lower depressive symptoms and better QOL than the control group up to 15 years later. Early implementation of cognitive-behavioral interventions may influence long-term psychosocial functioning in breast cancer survivors.
RCT Entities:
BACKGROUND:Breast cancer survivors experience long-term physical and psychological sequelae after their primary treatment that negatively influence their quality of life (QOL) and increase depressive symptoms. Group-based cognitive-behavioral stress management (CBSM) delivered after surgery for early-stage breast cancer was previously associated with better QOL over a 12-month follow-up and with fewer depressive symptoms up to 5 years after study enrollment. This 8- to 15-year follow-up (median, 11 years) of a previously conducted trial (NCT01422551) evaluated whether women in this cohort receiving CBSM had fewer depressive symptoms and better QOL than controls at an 8- to 15-year follow-up. METHODS:Women with stage 0 to IIIb breast cancer were initially recruited 2 to 10 weeks after surgery and randomized to a 10-week CBSM intervention or a 1-day psychoeducational control group. One hundred women (51 CBSM patients and 49 controls) were recontacted 8 to 15 years after study enrollment to participate in a follow-up assessment. The Center for Epidemiologic Studies-Depression (CES-D) scale and the Functional Assessment of Cancer Therapy-Breast (FACT-B) were self-administered. Multiple regression was employed to evaluate group differences on the CES-D scale and FACT-B over and above effects of confounding variables. RESULTS:Participants assigned to CBSM reported significantly lower depressive symptoms (d, 0.63; 95% confidence interval [CI], 0.56-0.70) and better QOL (d, 0.58; 95% CI, 0.52-0.65) above the effects of the covariates. CONCLUSIONS:Women who received CBSM after surgery for early-stage breast cancer reported lower depressive symptoms and better QOL than the control group up to 15 years later. Early implementation of cognitive-behavioral interventions may influence long-term psychosocial functioning in breast cancer survivors.
Authors: Michael H Antoni; Sarah R Wimberly; Suzanne C Lechner; Aisha Kazi; Tammy Sifre; Kenya R Urcuyo; Kristin Phillips; Roselyn G Smith; Vida M Petronis; Sophie Guellati; Kurrie A Wells; Bonnie Blomberg; Charles S Carver Journal: Am J Psychiatry Date: 2006-10 Impact factor: 18.112
Authors: Deborah J Bowen; Catherine M Alfano; Bonnie A McGregor; Alan Kuniyuki; Leslie Bernstein; Kathy Meeske; Kathy B Baumgartner; Josala Fetherolf; Bryce B Reeve; Ashley Wilder Smith; Patricia A Ganz; Anne McTiernan; Rachel Ballard Barbash Journal: Breast Cancer Res Treat Date: 2007-01-27 Impact factor: 4.872
Authors: Melissa S Y Thong; Floortje Mols; Adrian A Kaptein; Dorry Boll; Caroline Vos; Johanna M A Pijnenborg; Lonneke V van de Poll-Franse; Nicole P M Ezendam Journal: Support Care Cancer Date: 2018-09-13 Impact factor: 3.603
Authors: Jamie M Stagl; Suzanne C Lechner; Charles S Carver; Laura C Bouchard; Lisa M Gudenkauf; Devika R Jutagir; Alain Diaz; Qilu Yu; Bonnie B Blomberg; Gail Ironson; Stefan Glück; Michael H Antoni Journal: Breast Cancer Res Treat Date: 2015-10-30 Impact factor: 4.872
Authors: Michelle B Riba; Kristine A Donovan; Barbara Andersen; IIana Braun; William S Breitbart; Benjamin W Brewer; Luke O Buchmann; Matthew M Clark; Molly Collins; Cheyenne Corbett; Stewart Fleishman; Sofia Garcia; Donna B Greenberg; Rev George F Handzo; Laura Hoofring; Chao-Hui Huang; Robin Lally; Sara Martin; Lisa McGuffey; William Mitchell; Laura J Morrison; Megan Pailler; Oxana Palesh; Francine Parnes; Janice P Pazar; Laurel Ralston; Jaroslava Salman; Moreen M Shannon-Dudley; Alan D Valentine; Nicole R McMillian; Susan D Darlow Journal: J Natl Compr Canc Netw Date: 2019-10-01 Impact factor: 11.908
Authors: Leeat Granek; Ora Nakash; Samuel Ariad; Wendy Chen; Shira Birenstock-Cohen; Shahar Shapira; Merav Ben-David Journal: Support Care Cancer Date: 2017-06-26 Impact factor: 3.603
Authors: Heather Greenlee; Melissa J DuPont-Reyes; Lynda G Balneaves; Linda E Carlson; Misha R Cohen; Gary Deng; Jillian A Johnson; Matthew Mumber; Dugald Seely; Suzanna M Zick; Lindsay M Boyce; Debu Tripathy Journal: CA Cancer J Clin Date: 2017-04-24 Impact factor: 508.702